Moderna News - August 28, 2026

🔴 Moderna is trading 6% down today after upsized $2.6 billion note offering raises dilution concerns

Moderna is trading 5.59% down at $134.79 after pricing an upsized $2.6 billion private placement of convertible senior notes due 2032, raising dilution...

Moderna Secures FDA Approval for 2026 Vaccines, Targeting XFG Variant

The U.S. Food and Drug Administration (FDA) approved Moderna’s Spikevax and mNEXSPIKE vaccines on August 27, 2026. These updated formulations target the...